Ibex Gale
Ibex Gale, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Great Britain. Founded in 2015, the company has rapidly established itself as a leader in providing innovative solutions for drug development and regulatory compliance. With a focus on clinical trial management and data analytics, Ibex Gale offers unique services that streamline processes and enhance efficiency for clients across Europe and North America. The company’s commitment to quality and precision has earned it a strong market position, recognised for its expertise in navigating complex regulatory landscapes. Notable achievements include successful collaborations with major pharmaceutical firms, underscoring its reputation as a trusted partner in the industry. Ibex Gale continues to drive advancements in healthcare, making significant contributions to the development of life-saving therapies.
DitchCarbon Score
How does Ibex Gale's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ibex Gale's score of 8 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ibex Gale's reported carbon emissions
In 2023, Ibex Gale reported a total of approximately 6,730 kg CO2e in emissions, with all emissions classified under Scope 3. This includes about 4,790 kg CO2e from capital goods and approximately 1,940 kg CO2e from business travel. Notably, there were no reported emissions under Scope 2, indicating a potential focus on reducing indirect emissions associated with energy consumption. In 2022, the company’s emissions were higher, totalling about 36,680 kg CO2e, primarily from Scope 3 sources, which included approximately 27,900 kg CO2e from purchased goods and services and about 8,780 kg CO2e from business travel. Despite these figures, Ibex Gale has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of formal climate pledges or science-based targets suggests that while the company is tracking its emissions, it may need to establish clearer commitments to enhance its climate strategy and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | 36,680 | 0,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ibex Gale is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
